[1]姜磊.嗜铬细胞瘤的放射性核素诊断和治疗[J].国际放射医学核医学杂志,2008,32(5):278-281.
　JIANG Lei.The role of the radionuclide in the diagnosis and management of pheochromocytoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):278-281.
点击复制

嗜铬细胞瘤的放射性核素诊断和治疗(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第5期
页码:
278-281
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The role of the radionuclide in the diagnosis and management of pheochromocytoma
作者:
姜磊
200025 上海, 上海交通大学附属瑞金医院核医学科
Author(s):
JIANG Lei
Department of Nuclear Medicine, Shanghai Ruijin Hospital Affiliated Shanghai Jiaotong University, Shanghai 200025, China
关键词:
嗜铬细胞瘤; 副神经节瘤; 肾上腺外; 放射性核素显像; 氟脱氧葡萄糖F18; 3-碘苄胍
Keywords:
Pheochromocytoma; Paraganglioma;  extra-adrenal; Badionuclide imaging; Fhoradeoxyghcose F18; 3-lodobenzylguanidine
摘要:
嗜铬细胞瘤和副神经节瘤可大量合成和分泌儿茶酚胺,使患者出现高血压危象等许多临床危急症状,其诊断和治疗很大程度上依赖于病灶的定性、定位。随着分子影像学和核医学的发展,不仅提高了对嗜铬细胞瘤和副神经节瘤诊断的敏感性和准确性,而且能对恶性嗜铬细胞瘤特别是伴有转移的患者进行放射性核素治疗提供一种新的临床治疗手段。综述了放射性核素在嗜铬细胞瘤、副神经节瘤及家族性嗜铬细胞瘤的诊断以及在恶性嗜铬细胞瘤治疗中的应用策略进行综述。
Abstract:
Pheochromocytomas and paragangliomas can synthesise and secrete catecholamines, causing a variety of clinical symptoms, such as hypertensive crisis.The diagnosis and management of pheochromocytomas and paragangliomas largely depend on the qualitation and location of the tumor.With the development of molecular imaging and nuclear medicine, they make the diagnosis of pheochromocytomas and paragangliomas more sensitive and accurate, and provide a new treatment for patients with malignant pheochromocytomas especially that with metastasis.The article focuses on the radionuclide in the diagnosis of pheochromocytomas, paragangliomas and familial pheochromocytomas, and the management of malignant pheochromocytomas.

参考文献/References:

[1] Yeo H,Roman S.Pheochromocytoma and functional paraganglioma[J].Curr Opin Oncol,2005,17(1):13-18.
[2] Omura M,Saito J,Yamaguchi K,et al.Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan[J].Hypertens Res,2004,27(3):193-202.
[3] 林薇,李红.嗜铬细胞瘤定位核素诊断方法的研究进展[J].国际内分泌代谢杂志,2006,26(6):418-420.
[4] Ilias I,Pacak K.Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma[J].J Clin Endocrinol Metab,2004,89(2):479-491.
[5] Maurea S,Klain M,Mainolfi C,et al.The diagnositic role of radionuclide imaging in evaluation of patients with non-hypersecreting adrenal masses[J].J Nucl Med,2001,42(6):884-892.
[6] 朱承谟.核医学影像与实践[M].上海:科技教育出版社,2001:193.
[7] Moreira SG Jr,Pow-Sang JM.Evaluation and management of adrenal masses[J].Cancer Control,2002,9(4):326-334.
[8] Shulkin BL,Thompson NW,Shapiro B,et al.Pheochromocytomas:imaging with 2-[fluorine-18] fluoro-2-deoxy-d-glucose PET[J].Radiology,1999,212(1):35-41.
[9] Trampal C,Engler H,Juhlin C.Pheochromocytomas:detection with 11C hydroxyephedrine PET[J].Radjology,2004,230(2):423-428.
[10] 孙则禹,甘卫东,郭宏骞,等.儿茶酚胺增多症(附95例报告)[J].中华泌尿外科杂志,2003,24(9):583-585.
[11] Lumaehi F,Tregnaghi A,Zucchetta P,et al.Sensitivity and positive predictive value of CT,MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas:a prospective study[J].Nucl Med Commun,2006,27(7):583-587.
[12] Sahdev A,Sohaib A,Monson JP,et al.CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas)[J].Eur Radiol,2005,15(1):85-92.
[13] 吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.533
[14] 邓建华,白进良.家族性嗜铬细胞瘤的研究进展[J].国际泌尿系统杂志,2006,26(1):68-72.
[15] Chrisoulidou A,Kaltsas G,llias I,et al.The diagnosis and management of malignant pheochromocytoma and paraganglioma[J].Endocr Relat Cancer,2007,14(3):569-585.
[16] John H,Ziegler WH,Hauri D,et al.Pheochromocytomas:can malignant potential be predicted?[J].Urology,1999,53(4):679-683.
[17] Safford SD,Coleman RE,Gockerman JP,et al.Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma[J].Surgery,2003,134(6):956-962.
[18] Ahlman H.Malignant pheochromocytoma:state of the field with future projections[J].Ann N Y Aead Sci,2006,1073:449-464.

相似文献/References:

[1]倪明,汪世存,潘博,等.腹膜后副神经节瘤18F-FDG PET/CT显像1例[J].国际放射医学核医学杂志,2013,37(4):253.[doi:10.3760/cma.j.issn.1673-4114.2013.04.015]
[2]谢君伟,左庆国,王都.多层螺旋CT与MRI在嗜铬细胞瘤诊断中的价值[J].国际放射医学核医学杂志,2011,35(4):245.[doi:10.3760/cma.j.issn.1673-4114.2011.04.013]
　XIE Jun-wei,ZUO Qing-guo,WANG Du.The value of CT and MRI in diagnosis of pheochromocytoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):245.[doi:10.3760/cma.j.issn.1673-4114.2011.04.013]
[3]马寄晓,叶大铸.奥曲肽及其类似物用于肿瘤治疗的进展[J].国际放射医学核医学杂志,2005,29(2):79.
　MA Ji-xiao,YE Da-zhu.Advances in tumor treatment with labeled somatostatin analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):79.
[4]袁志斌.PET显像在内分泌肿瘤中的应用[J].国际放射医学核医学杂志,2003,27(5):208.
　YUAN Zhi-bin.The application of PET in endocrine tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(5):208.
[5]罗全勇.MIBG及其衍生物的研究进展[J].国际放射医学核医学杂志,2002,26(5):216.
　LUO Quan-yong.The recent research progress of MIBG and its derivatives[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):216.
[6]叶大铸,马寄晓.奥曲肽及其类似物用于肿瘤诊断的进展[J].国际放射医学核医学杂志,2003,27(3):97.
　YE Da-zhu,MA Ji-xiao.Advances in tumor diagnosis with labeled somatostatin analogues[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(5):97.

备注/Memo

备注/Memo:
收稿日期:2008-04-03。
更新日期/Last Update: 1900-01-01